E-Mail IMAGE: Jeff Wrana, left, is seen in this undated file photo at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada. view more Credit: Sinai Health A robotics platform designed by Toronto researchers to screen thousands of COVID-19 samples at once has the potential to revolutionize how labs track the spread of viruses and other pathogens, according to new findings. The study, out Wednesday in Nature Communications, found that the next-generation, ultra-high-throughput sequencing platform, called C19-SPAR-Seq, designed by researchers from the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health, has a sensitivity rate greater than 95 per cent in positive cases during peak onset.